188 related articles for article (PubMed ID: 31502101)
21. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
22. The effect of macrocyclic chelators on the targeting properties of the 68Ga-labeled gastrin releasing peptide receptor antagonist PEG2-RM26.
Varasteh Z; Mitran B; Rosenström U; Velikyan I; Rosestedt M; Lindeberg G; Sörensen J; Larhed M; Tolmachev V; Orlova A
Nucl Med Biol; 2015 May; 42(5):446-454. PubMed ID: 25684649
[TBL] [Abstract][Full Text] [Related]
23. Preclinical Evaluation of a Tailor-Made DOTA-Conjugated PSMA Inhibitor with Optimized Linker Moiety for Imaging and Endoradiotherapy of Prostate Cancer.
Benešová M; Schäfer M; Bauder-Wüst U; Afshar-Oromieh A; Kratochwil C; Mier W; Haberkorn U; Kopka K; Eder M
J Nucl Med; 2015 Jun; 56(6):914-20. PubMed ID: 25883127
[TBL] [Abstract][Full Text] [Related]
24. "To serve and protect": enzyme inhibitors as radiopeptide escorts promote tumor targeting.
Nock BA; Maina T; Krenning EP; de Jong M
J Nucl Med; 2014 Jan; 55(1):121-7. PubMed ID: 24287321
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and evaluation of
Yang Y; Zhang J; Zou H; Shen Y; Deng S; Wu Y
J Cancer; 2021; 12(1):244-252. PubMed ID: 33391421
[No Abstract] [Full Text] [Related]
26. A new (68)Ga-labeled BBN peptide with a hydrophilic linker for GRPR-targeted tumor imaging.
Pan D; Xu YP; Yang RH; Wang L; Chen F; Luo S; Yang M; Yan Y
Amino Acids; 2014 Jun; 46(6):1481-9. PubMed ID: 24633452
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of a para-carboxylated benzyl-DOTA for labeling peptides and polypeptides.
Suzuki H; Ichinohe K; Araki M; Muramatsu S; Uehara T; Arano Y
Nucl Med Biol; 2022; 114-115():18-28. PubMed ID: 36088873
[TBL] [Abstract][Full Text] [Related]
28. 44Sc-DOTA-BN[2-14]NH2 in comparison to 68Ga-DOTA-BN[2-14]NH2 in pre-clinical investigation. Is 44Sc a potential radionuclide for PET?
Koumarianou E; Loktionova NS; Fellner M; Roesch F; Thews O; Pawlak D; Archimandritis SC; Mikolajczak R
Appl Radiat Isot; 2012 Dec; 70(12):2669-76. PubMed ID: 23037921
[TBL] [Abstract][Full Text] [Related]
29. Development of Novel PSMA Ligands for Imaging and Therapy with Copper Isotopes.
Carlos Dos Santos J; Beijer B; Bauder-Wüst U; Schäfer M; Leotta K; Eder M; Benešová M; Kleist C; Giesel F; Kratochwil C; Kopka K; Haberkorn U; Mier W
J Nucl Med; 2020 Jan; 61(1):70-79. PubMed ID: 31541034
[TBL] [Abstract][Full Text] [Related]
30. N-terminal modifications improve the receptor affinity and pharmacokinetics of radiolabeled peptidic gastrin-releasing peptide receptor antagonists: examples of 68Ga- and 64Cu-labeled peptides for PET imaging.
Gourni E; Mansi R; Jamous M; Waser B; Smerling C; Burian A; Buchegger F; Reubi JC; Maecke HR
J Nucl Med; 2014 Oct; 55(10):1719-25. PubMed ID: 25146125
[TBL] [Abstract][Full Text] [Related]
31. Novel
Lucente E; Liu H; Liu Y; Hu X; Lacivita E; Leopoldo M; Cheng Z
Bioconjug Chem; 2018 May; 29(5):1595-1604. PubMed ID: 29587479
[TBL] [Abstract][Full Text] [Related]
32. GRP receptor-targeted PET of a rat pancreas carcinoma xenograft in nude mice with a 68Ga-labeled bombesin(6-14) analog.
Schuhmacher J; Zhang H; Doll J; Mäcke HR; Matys R; Hauser H; Henze M; Haberkorn U; Eisenhut M
J Nucl Med; 2005 Apr; 46(4):691-9. PubMed ID: 15809493
[TBL] [Abstract][Full Text] [Related]
33. Structural modifications of ⁹⁹mTc-labelled bombesin-like peptides for optimizing pharmacokinetics in prostate tumor targeting.
Liolios CC; Fragogeorgi EA; Zikos C; Loudos G; Xanthopoulos S; Bouziotis P; Paravatou-Petsotas M; Livaniou E; Varvarigou AD; Sivolapenko GB
Int J Pharm; 2012 Jul; 430(1-2):1-17. PubMed ID: 22459664
[TBL] [Abstract][Full Text] [Related]
34. Approaches to improve metabolic stability of a statine-based GRP receptor antagonist.
Popp I; Del Pozzo L; Waser B; Reubi JC; Meyer PT; Maecke HR; Gourni E
Nucl Med Biol; 2017 Feb; 45():22-29. PubMed ID: 27865999
[TBL] [Abstract][Full Text] [Related]
35. Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).
Fournier P; Dumulon-Perreault V; Ait-Mohand S; Tremblay S; Bénard F; Lecomte R; Guérin B
Bioconjug Chem; 2012 Aug; 23(8):1687-93. PubMed ID: 22770480
[TBL] [Abstract][Full Text] [Related]
36. Targeting the Neuropeptide Y1 Receptor for Cancer Imaging by Positron Emission Tomography Using Novel Truncated Peptides.
Zhang C; Pan J; Lin KS; Dude I; Lau J; Zeisler J; Merkens H; Jenni S; Guérin B; Bénard F
Mol Pharm; 2016 Nov; 13(11):3657-3664. PubMed ID: 27669056
[TBL] [Abstract][Full Text] [Related]
37. Preparation and evaluation of the tumor-specific antigen-derived synthetic mucin 1 peptide: A potential candidate for the targeting of breast carcinoma.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2016 Jul; 43(7):403-9. PubMed ID: 27179249
[TBL] [Abstract][Full Text] [Related]
38. DOTA-PESIN, a DOTA-conjugated bombesin derivative designed for the imaging and targeted radionuclide treatment of bombesin receptor-positive tumours.
Zhang H; Schuhmacher J; Waser B; Wild D; Eisenhut M; Reubi JC; Maecke HR
Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1198-208. PubMed ID: 17262215
[TBL] [Abstract][Full Text] [Related]
39. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
[TBL] [Abstract][Full Text] [Related]
40. In vitro and in vivo evaluation of 64Cu-labeled DOTA-linker-bombesin(7-14) analogues containing different amino acid linker moieties.
Parry JJ; Kelly TS; Andrews R; Rogers BE
Bioconjug Chem; 2007; 18(4):1110-7. PubMed ID: 17503761
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
